Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиGuardion Health Sciences Мультипликаторы 2011-2024 | GHSI
Мультипликаторы по годам Guardion Health Sciences
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.5 | -0.0 | -8.1 | -1.0 | - | - | - | - | - | - | - | - |
P/S |
0.6 | 0.0 | 36.8 | 12.4 | - | - | - | - | - | - | - | - |
EPS |
-14.2 | -52.2 | -0.6 | -1.8 | -0.4 | -0.5 | -0.3 | -0.5 | - | - | - | - |
EV (Enterprise Value) |
4.96 млн | -2.62 млн | 62.4 млн | 962 тыс. | -176 тыс. | -4.24 млн | 545 тыс. | 1.46 млн | - | - | - | - |
EBITDA per Share |
-14.4 | -50.6 | -0.581 | -1.37 | - | - | - | - | - | - | - | - |
EV/EBITDA |
0.1 | -7.4 | -0.0 | - | - | - | - | - | - | - | - | |
PEG |
- | 0.12 | 0.07 | - | - | - | - | - | - | - | - | |
P/B |
0.5 | 0.0 | 8.2 | 0.9 | - | - | - | - | - | - | - | - |
P/CF |
-1.0 | -0.0 | -8.6 | -1.8 | - | - | - | - | - | - | - | - |
ROE % |
-188.46 | -110.98 | -100.66 | -90.41 | - | - | - | - | - | - | - | - |
ROA % |
-68.81 | -105.47 | -86.93 | -84.48 | - | - | - | - | - | - | - | - |
ROCE % |
-220.01 | -110.98 | -96.76 | -71.66 | - | - | - | - | - | - | - | - |
Current Ratio |
2.5 | 20.2 | 8.5 | 28.9 | - | - | - | - | - | - | - | - |
DSO |
55.1 | 35.9 | 2.2 | 31.7 | - | - | - | - | - | - | - | - |
DIO |
97.5 | 33.3 | 72.2 | 332.5 | - | - | - | - | - | - | - | - |
DPO |
49.2 | 37.6 | 114.1 | 138.1 | - | - | - | - | - | - | - | - |
Операционный цикл |
152.6 | 69.2 | 74.4 | 364.2 | - | - | - | - | - | - | - | - |
Финансовый цикл |
103.4 | 31.6 | -39.7 | 226.1 | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Guardion Health Sciences
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.29 | -0.93 | 0.42 | - | -0.67 | 2.97 | -6.77 | - | -0.12 | -0.19 | -0.13 | - | -0.15 | -0.05 | -0.18 | - | -0.07 | -0.14 | -0.07 | - | -0.11 | -0.09 | -0.12 | - | -0.07 | -0.04 | -0.03 | - | -0.06 | -0.06 | -0.05 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -1.15 | - | -0.64 | -0.88 | -2.94 | - | -0.1 | -0.18 | -0.12 | - | -0.14 | -0.05 | -0.18 | - | -0.07 | -0.12 | -0.06 | - | -0.05 | -0.06 | -0.11 | - | -0.06 | -0.03 | -0.03 | - | -0.04 | -0.05 | -0.03 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-8.94 | -17.65 | 15.14 | -16.20 | -24.43 | -28.79 | -56.93 | -25.92 | -51.09 | -68.04 | -64.79 | -61.04 | -80.86 | -75.52 | -92.58 | -56.70 | -124.14 | -171.74 | -203.18 | -197.48 | -197.48 | -463.92 | -740.99 | -1102.72 | -768.85 | -768.85 | -434.98 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-5.03 | -10.83 | 10.12 | -7.43 | -15.23 | -20.13 | -43.38 | -24.78 | -46.51 | -60.44 | -56.62 | -52.71 | -71.23 | -68.02 | -84.55 | -52.98 | -111.34 | -151.17 | -176.63 | -170.91 | -192.40 | -155.54 | -117.99 | -42.18 | -477.62 | -891.56 | -1395.37 | -1313.09 | -1313.09 | -877.65 | -362.23 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-8.18 | -16.36 | -24.13 | -30.25 | -38.47 | -38.52 | -42.31 | -25.92 | -51.19 | -68.23 | -64.99 | -61.02 | -81.07 | -75.85 | -90.91 | -53.24 | -89.05 | -104.80 | -122.71 | -150.30 | -150.30 | -447.62 | -739.46 | -1090.54 | -757.41 | -757.41 | -424.29 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
2.5 | 2.2 | 2.4 | 2.5 | 16.3 | 17.6 | 17.3 | 20.2 | 19.6 | 20.7 | 36.9 | 7.3 | 7.3 | 7.3 | 7.3 | 15.2 | 15.2 | 15.2 | 15.2 | 7.4 | 7.4 | 7.4 | 7.4 | - | - | - | - | 0.4 | - | - | - | 0.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
45.4 | 57.3 | 55.4 | - | 66.4 | 58.5 | 69.1 | - | 60.2 | 72.7 | 14.9 | - | 4.0 | 0.9 | 16.6 | - | 44.4 | 27.4 | 20.0 | - | 8.8 | 11.7 | 23.9 | - | 105.9 | 110.7 | 60.7 | - | 4.5 | 5.2 | 4.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
120.7 | 165.1 | 152.4 | - | 106.1 | 61.6 | 42.1 | - | 45.3 | 85.4 | 231.0 | - | 307.8 | 54.5 | 291.0 | - | 399.6 | 292.3 | 326.4 | - | 260.5 | 372.2 | 295.1 | - | 469.2 | 475.5 | 400.6 | - | 174.6 | 311.6 | 238.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
45.4 | 55.5 | 59.3 | - | 61.9 | 54.5 | 49.1 | - | 50.6 | 68.5 | 287.7 | - | 486.4 | 86.1 | 308.4 | - | 90.3 | 66.1 | 34.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
166.1 | 222.3 | 207.8 | - | 172.5 | 120.1 | 111.2 | - | 105.5 | 158.1 | 245.9 | - | 311.9 | 55.4 | 307.6 | - | 444.0 | 319.7 | 346.5 | - | 269.2 | 383.8 | 318.9 | - | 575.1 | 586.2 | 461.3 | - | 179.1 | 316.8 | 243.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
120.7 | 166.8 | 148.5 | - | 110.6 | 65.6 | 62.1 | - | 54.9 | 89.6 | -41.8 | - | -174.6 | -30.8 | -0.7 | - | 353.6 | 253.6 | 312.2 | - | 269.2 | 383.8 | 318.9 | - | 575.1 | 586.2 | 461.3 | - | 179.1 | 316.8 | 243.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD